Pfizer and Astellas have bagged FDA approval for Xtandi in metastatic castration-sensitive prostate cancer (CSPC), cancelling out a brief lead for rival drug Erleada from Johnson & Johnson.

CSPC is one of the largest and oldest pharmaceutical companies in China. Anchored by its nervous system business segment due to its flagship drug NBP, CSPC has a portfolio of innovative and ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.

The Center for the Study of Psychoanalysis and Culture (CSPC) is a trans-disciplinary center housed within the University at Buffalo English Department and supported by the department in conjunction ...

CSPC operates in a fast-growing and rapidly changing environment. Like most healthcare sectors in China, drug manufacturing has grown faster than GDP, and is projected to continue this trend over ...

CSPC Pharmaceutical Group Ltd. has obtained clearance from China’s National Medical Products Administration (NMPA) to conduct clinical trials with JMT-108 for advanced malignant tumors.

CSPC PHARMA (01093.HK) repurchased 6.3 million shares today (3rd) at a price per share of between $4.56 and $4.72, involving $29.3301 million, according to CSPC PHARMA's announ... CSPC PHARMA ...